Improving sleep health to manage Type 1 diabetes in young adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effects of a cognitive behavioral sleep intervention (CB-sleep) on sleep health and diabetes management in young adults aged 18-31 with Type 1 diabetes. Participants will be randomly assigned to either the CB-sleep intervention or an enhanced usual care control group. The study will assess various sleep health dimensions, glycemic control, and diabetes self-management outcomes over a period of 9 months, using both self-reported questionnaires and objective measures. The goal is to determine if improving sleep health can lead to better glycemic control and overall diabetes management in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 18 to 40 years
* Type 1 Diabetes at least 1 year
* One or more sleep health dimension out of range

Exclusion Criteria:

* Non-English speaking
* A1C \< 7% or \>80% time in glucose range

Where it's running

• Emory University
  Atlanta, Georgia, United States Recruiting

Study contacts

• Principal investigator: Stephanie Griggs, PhD — Emory University
• Study coordinator: Stephanie Griggs, PhD
• Email: Stephanie.griggs2@emory.edu
• Phone: 404-544-9915

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Continuous Glucose Monitor Accuracy and Safety in Adults with Type 1 Diabetes

  This study tests a new real-time CGM system in adults with type 1 diabetes to see if its readings match venous blood glucose measurements.

  Recruiting SiBionics, Co, Ltd · Zibo, Shandong · NCT07745244

• Thrive With Type 1 Diabetes: A Behavioral Program to Improve Glucose and Sleep

  A behavioral program is being tested to see if it helps adults with type 1 diabetes better manage their sleep and glucose targets.

  Recruiting at 2 sites Emory University · Atlanta, Georgia and 1 other locations · NCT07522866

• Cardiometabolic effects of non-nutritive sweeteners in Type 1 diabetes

  This study tests whether non-nutritive sweeteners in a 12-ounce cherry Gatorade drink affect blood sugar control and cardiovascular markers in teens and young adults with Type 1 diabetes.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT07434544

• Wearable continuous glucose and ketone monitor for adults with type 1 diabetes

  This trial will test if a new wearable device can continuously and accurately measure glucose and ketone levels in adults with type 1 diabetes.

  Recruiting at 2 sites Henan University of Science and Technology · Shijiazhuang, Hebei and 1 other locations · NCT07139808

• Tirzepatide for obesity in people with type 1 diabetes

  This trial will test whether tirzepatide helps adults with type 1 diabetes and obesity lose weight and is safe for them.

  Recruiting Phase 4 Dasman Diabetes Institute · Kuwait City, Sharq · NCT07096908

• New real-time continuous glucose monitor accuracy and safety in adults with type 1 diabetes

  This project will test a new real-time continuous glucose monitor to see if its sensor readings match lab venous plasma (YSI) measurements in adults with type 1 diabetes.

  Recruiting Henan University of Science and Technology · Luoyang, Henan · NCT07092761

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.